Davis Investment Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Davis Investment Partners’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.31M	Buy	11,517 +6,817	+145%	+$1.41M	0.82%	19
2025 Q4	$976K	Hold	4,700	–	–	0.34%	52
2025 Q3	$872K	Hold	4,700	–	–	0.3%	54
2025 Q2	$762K	Hold	4,700	–	–	0.27%	61
2025 Q1	$732K	Hold	4,700	–	–	0.32%	56
2024 Q4	$805K	Hold	4,700	–	–	0.34%	56
2024 Q3	$810K	Hold	4,700	–	–	0.34%	56
2024 Q2	$754K	Hold	4,700	–	–	0.31%	60
2024 Q1	$709K	Hold	4,700	–	–	0.31%	58
2023 Q4	$744K	Hold	4,700	–	–	0.36%	50
2023 Q3	$689K	Hold	4,700	–	–	0.37%	50
2023 Q2	$738K	Hold	4,700	–	–	0.35%	52
2023 Q1	$727K	Hold	4,700	–	–	0.39%	42
2022 Q4	$761K	Buy	+4,700	New	+$693K	0.38%	46

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Davis Investment Partners's FBT Position: Q1 2026 in Review

Davis Investment Partners increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 145% in Q1 2026, buying an estimated $1.41M and bringing the position to 11,517 shares worth $2.31M. The position accounts for 0.82% of the portfolio, ranked #19.

Davis Investment Partners first reported a position in FBT in Q4 2022 and has held it in 14 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Davis Investment Partners held 11,517 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.31M as of Q1 2026.
Davis Investment Partners bought 6,817 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $1.41M.
First Trust NYSE Arca Biotechnology Index Fund made up 0.82% of Davis Investment Partners's portfolio in Q1 2026, its #19 holding.
Davis Investment Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and has held it in 14 quarters since.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Davis Investment Partners's 13F filing for Q1 2026, filed 20 Apr 2026.